Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tscan Therapeutics Inc (NQ: TCRX )

2.320 -0.130 (-5.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,358
Open 2.370
Bid (Size) 2.310 (2)
Ask (Size) 2.340 (2)
Prev. Close 2.450
Today's Range 2.280 - 2.419
52wk Range 1.450 - 4.560
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
TScan Therapeutics Announces First Patient Dosed in Phase 1 Umbrella Clinical Trial Evaluating TSC-100 and TSC-101 for the Treatment of Hematologic Malignancies
Patient treated with TSC-101, the first clinical cell therapy product targeting minor histocompatibility antigen HA-2 to treat leukemia and prevent relapse following hematopoietic cell transplantation 
From TScan Therapeutics, Inc.
Via Globe NewsWire

Performance

YTD
+35.67%
+35.67%
1 Month
-15.94%
-15.94%
3 Month
+46.84%
+46.84%
6 Month
-12.78%
-12.78%
1 Year
-31.56%
-31.56%

More News

Read More
TScan Therapeutics to Participate in the Barclays Global Healthcare Conference
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics's Return On Capital Employed Insights
Via Benzinga
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Upcoming Milestones
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference
From TScan Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Announces Upcoming Virtual Investor Event
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition
From TScan Therapeutics, Inc.
Via Globe NewsWire
TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
From TScan Therapeutics, Inc.
Via Globe NewsWire
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Via Benzinga
Why Lululemon Athletica Is Trading Higher By 11%, Here Are 36 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.